Ketamine Wellness Centers Podcast

This episode of the podcast features an interview between Harmony Green, Health and Wellness Coordinator at Ketamine Wellness Centers, and Psychologist, Dr. Ellen Diamond, who is also one of the founders at Ketamine Wellness Centers. Due to the pandemic you may be feeling stressed and anxious about the coronavirus (COVID-19). Given this unprecedented event we are currently grappling with, Psychologist, Dr. Ellen Diamond is providing expert advice on strategies for staying well through this difficult time. Many thanks to Dr. Ellen Diamond for sharing these strategies with us and you all.

In this latest podcast episode, we interview Harmony Green a Health and Wellness Coordinator at Ketamine Wellness Centers to discover the benefits of Facilitated Treatment Support in conjunction with Ketamine Infusion Therapy.

As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention.

This episode is about Treatment Resistant Depression and the requirements of Spravato, as such. We touch on:

- The clinical definition of Treatment Resistant Depression

- What to do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc?

- Does Spravato require patients to be prescribed to an antidepressant to qualify for using it?

- Is Spravato utilizing the full potential of Ketamine to treat Depression?

As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention.One thing that raised the eyebrows of everybody on the clinical team here at KWC relates to the recommended dosing of Spravato.

On this episode, we discuss:

- What is the recommended dosing during the stabilization and maintenance treatment phases?

- Is the dosing variable from patient to patient or fixed?

- What are the implications of utilizing a non-variable prescription for dosing?

www.ketaminewellnesscenters.com/category/podcast/

As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention.

This episode focuses on the cost of Spravato to the provide, end user, and insurer:

- What are the preliminary cost estimates for Spravato (wholesale)

- Can we estimate the cost to the patient?

- Will insurance cover the drug?

- How will the treatment schedule effect the cost?

www.ketaminewellnesscenters.com/category/podcast/

A Closer Look at Spravato (Esketamine): How will it be administered?

As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention.

This episode focuses on how Spravato is administered:

Is intranasal delivery effective?

What type of clinical environments can provide Spravato to patients?

What duration of time will patients have to commit to treatment?

www.ketaminewellnesscenters.com/category/podcast/

Fact or Fiction?

Topic: Ketamine Infusions are Addictive

Ketamine has several reputations: surgical anesthetic, life saving battlefield necessity, veterinary medicine, club drug, breakthrough depression treatment, etc.

Many medications present the potential for chemical addiction to take hold in individuals. We know that this can absolutely be the case for self-medicating and recreational of Ketamine, in moderate to high doses. But should we worry about addiction when applied to the clinical, therapeutic application of Ketamine via low-dose infusion?

Jonathan DelosSantos, Clinical Administrator at Ketamine Wellness Centers - Phoenix, answers the question of whether Ketamine under our clinical protocol is addictive or not.

www.ketaminewellnesscenters.com

This episode of the podcast features an interview between Kevin Nicholson, CEO of Ketamine Wellness Centers, and a longtime patient of the Mesa, Arizona clinic, Andy, who has suffered from Depression since he was an adolescent. For as long as Andy can remember, the fog of Depression has dictated much of his life. After trying virtually every prescription medication available to get relief, Andy came across Ketamine Therapy in an internet search. Fast forward two years and the fog of Depression has been lifted thanks to an effective treatment protocol. Many thanks to Andy for sharing his story with us and you all.

www.ketaminewellnesscenters.com

Fact or Fiction?

Topic: There Is A Harmful Interaction Between Ketamine And Prescribed Antidepressant Medications

When depression patients come to us seeking the therapeutic effects that Ketamine can provide, they are frequently prescribed to and utilizing antidepressant medications (SSRI,SNRI). A common question we get at KWC is whether there is a harmful interaction that may occur between the Ketamine and antidepressant medications. In other words, will the Ketamine be less effective? And are there harmful side effects to take into consideration for someone who is currently utilizing antidepressants?

Clinical Administrator, John DelosSantos, tackles these questions and clears the air on this misunderstood issue.

Special thanks to listener, Emily, for submitting this Fact of Fiction topic.

In this episode of the KWC Podcast, we speak with three depression patients who are currently utilizing Ketamine Infusion Treatments about what the experience is like, what to expect, as well as recommendations/advice for others who are considering this therapy for themselves.

www.ketaminewellnesscenters.com